Acting as our North Star
This page shares an overview of scientific publications related to the Immunogram.
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry
